Literature DB >> 1674785

Ovarian cancer and long-term tamoxifen in premenopausal women.

D V Spicer, M C Pike, B E Henderson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1674785     DOI： 10.1016/0140-6736(91)93096-r

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Tamoxifen prevents premalignant changes of breast, but not ovarian, cancer in rats at high risk for both diseases.

Authors:  Alison Y Ting; Bruce F Kimler; Carol J Fabian; Brian K Petroff
Journal:  Cancer Prev Res (Phila)       Date:  2008-12

Review 2.  Gynaecologic effects of tamoxifen.

Authors:  D Y Kuo; C D Runowicz
Journal:  Med Oncol       Date:  1995-06       Impact factor: 3.064

3.  Tamoxifen treatment in premenopausal breast cancer patients may be associated with ovarian overstimulation, cystic formations and fibroid overgrowth.

Authors:  I Cohen; D J Rosen; M Altaras; Y Beyth; J Shapira; D Yigael
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640

4.  Ovarian cysts in women receiving tamoxifen for breast cancer.

Authors:  M J Mourits; E G de Vries; P H Willemse; K A ten Hoor; H Hollema; W J Sluiter; H W de Bruijn; A G van der Zee
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

Review 5.  Primary ovarian small cell carcinoma of pulmonary type with coexisting endometrial carcinoma in a breast cancer patient receiving tamoxifen: A case report and literature review.

Authors:  Lei Yin; Jianning Li; Yunhai Wei; Dejian Ma; Yamei Sun; Yanlai Sun
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

6.  Estrogen directly activates AID transcription and function.

Authors:  Siim Pauklin; Isora V Sernández; Gudrun Bachmann; Almudena R Ramiro; Svend K Petersen-Mahrt
Journal:  J Exp Med       Date:  2009-01-12       Impact factor: 14.307

Review 7.  Medical hypothesis: xenoestrogens as preventable causes of breast cancer.

Authors:  D L Davis; H L Bradlow; M Wolff; T Woodruff; D G Hoel; H Anton-Culver
Journal:  Environ Health Perspect       Date:  1993-10       Impact factor: 9.031

8.  Ovarian cancer risk in premenopausal and perimenopausal women treated with Tamoxifen: a case-control study.

Authors:  A J Swerdlow; M E Jones
Journal:  Br J Cancer       Date:  2007-02-06       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.